Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 3, 2011, Pages

  MohanKumar, Sheba M J ^a   Kasturi, Badrinarayanan S ^a   Shin, Andrew C ^a   Balasubramanian, Priya ^a   Gilbreath, Ebony T ^a   Subramanian, Madhan ^a   MohanKumar, Puliyur S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Nitration; Prolactin; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; ESTRADIOL; ESTROGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; NITRATE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYCLING; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL EXPOSURE; ENZYME SYNTHESIS; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; ESTRUS; ESTRUS CYCLE; FEMALE; HYPERPROLACTINEMIA; HYPOTHALAMUS; MEDIAN EMINENCE; NITRATION; NONHUMAN; OLD CONSTANT ESTROUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUBEROINFUNDIBULAR DOPAMINERGIC NEURON;

AGE FACTORS; ANIMALS; ARCUATE NUCLEUS; DOPAMINE; DOWN-REGULATION; DRUG IMPLANTS; ESTRADIOL; ESTRUS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERPROLACTINEMIA; HYPOTHALAMUS; INTERLEUKIN-1BETA; NITRIC OXIDE; OXIDATIVE STRESS; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 79954482502     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00481.2010     Document Type: Article

References (46)

1. Aguilar R, Bellido C, Garrido-Gracia JC, Alonso R, Sanchez-Criado JE. Estradiol and its membrane-impermeable conjugate estradiol-BSA inhibit tamoxifen-stimulated prolactin secretion in incubated rat pituitaries. Reproduction 131: 763-769, 2006.
2. Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Proc Natl Acad Sci USA 95: 7659-7663, 1998.
3. Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine [corrected] regulation of prolactin release. Prog Neurobiol 33: 399-447, 1989.
4. Brawer JR, Beaudet A, Desjardins GC, Schipper HM. Pathologic effect of estradiol on the hypothalamus. Biol Reprod 49: 647-652, 1993.
5. Brawer JR, Naftolin F, Martin J, Sonnenschein C. Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology 103: 501-512, 1978.
6. Brawer JR, Ruf KB, Naftolin F. Effects of estradiol-induced lesions of the arcuate nucleus on gonadotropin release in response to preoptic stimulation in the rat. Neuroendocrinology 30: 144-149, 1980.
7. Brawer JR, Schipper H, Naftolin F. Ovary-dependent degeneration in the hypothalamic arcuate nucleus. Endocrinology 107: 274-279, 1980.
8. Chao CC, Hu S, Ehrlich L, Peterson PK. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9: 355-365, 1995.
9. Chaturvedi K, Sarkar DK. Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment. Alcoholism Clin Exp Res 32: 806-813, 2008.
10. Clemens JA, Meites J. Neuroendocrine status of old constant-estrous rats. Neuroendocrinology 7: 249-256, 1971.
11. Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 24: 1-27, 2003.
12. Deak T, Bordner KA, McElderry NK, Barnum CJ, Blandino P Jr, Deak MM, Tammariello SP. Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Res Bull 64: 541-556, 2005.
13. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18: 1253-1258, 1998.
14. Gonzalez MC, Abreu P, Barroso-Chinea P, Cruz-Muros I, Gonzalez-Hernandez T. Effect of intracerebroventricular injection of lipopolysaccharide on the tuberoinfundibular dopaminergic system of the rat. Neuroscience 127: 251-259, 2004.
15. Gottschall PE, Meites J. Evidence for a permanent decline in tuberoinfundibular dopaminergic neuronal function after chronic estrogen treatment is terminated in Fischer 344 rats. Neuroendocrinology 44: 211-216, 1986.
16. Gottschall PE, Sarkar DK, Meites J. Persistence of low hypothalamic dopaminergic activity after removal of chronic estrogen treatment. Proc Soc Exp Biol Med 181: 78-86, 1986.
17. Goya RG, Lu JK, Meites J. Gonadal function in aging rats and its relation to pituitary and mammary pathology. Mech Ageing Dev 56: 77-88, 1990.
18. Hu S, Peterson PK, Chao CC. Cytokine-mediated neuronal apoptosis. Neurochem Int 30: 427-431, 1997.
19. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun 18: 195-199, 1993.
20. Imam SZ, el-Yazal J, Newport GD, Itzhak Y, Cadet JL, Slikker W Jr, Ali SF. Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Annals N Y Acad Sci 939: 366-380, 2001.
21. Ischiropoulos H, Duran D, Horwitz J. Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. J Neurochem 65: 2366-2372, 1995.
22. Jaques S Jr, Gala RR. The influence of oestrogen administration in vivo on in vitro prolactin release Interaction between dopamine and thyrotrophin releasing hormone. Acta Endocrinol 92: 437-447, 1979.
23. Jeng YJ, Kochukov M, Nauduri D, Kaphalia BS, Watson CS. Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol-pituitary tumor induction in Fischer 344 rats. Nutr Metab 7: 40.
24. Kasturi BS, MohanKumar SM, Sirivelu MP, MohanKumar PS. Chronic exposure to low levels of oestradiol-17beta affects oestrous cyclicity, hypothalamic norepinephrine and serum luteinising hormone in young intact rats. J Neuroendocrinol 21: 568-577, 2009.
25. Lawson DM. Evidence for a rapid in vivo effect on estradiol-17 beta on prolactin secretion in ovariectomized rats. Endocr Res Commun 6: 135-148, 1979.
26. Maeda T, Ikegami H, Sakata M, Yamaguchi M, Wada K, Koike K, Adachi K, Kurachi H, Hirota K, Miyake A. Intraventricular adminis-tration of estradiol modulates rat prolactin secretion and synthesis. J Endocrinol Invest 19: 586-592, 1996.
27. Meema S, Bunker ML, Meema HE. Preventive effect of estrogen on postmenopausal bone loss. Arch Intern Med 135: 1436-1440, 1975.
28. Meites J. Aging: hypothalamic catecholamines, neuroendocrine-immune interactions, and dietary restriction. Proc Soc Exp Biol Med 195: 304-311, 1990.
29. Meites J. Role of hypothalamic catecholamines in aging processes. Acta Endocrinol (Copenh) 125 Suppl 1: 98-103, 1991.
30. Mohankumar PS, Thyagarajan S, Quadri SK. Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging. Endocrinology 135: 119-126, 1994.
31. Mohankumar PS, Thyagarajan S, Quadri SK. Cyclic and age-related changes in norepinephrine concentrations in the medial preoptic area and arcuate nucleus. Brain Res Bull 38: 561-564, 1995.
32. MohanKumar SM, Smith CL, MohanKumar PS. Central adaptation to chronic administration of interleukin-1beta (IL-1beta) in rats. Brain Res Bull 62: 71-76, 2003.
33. Morel GR, Caron RW, Console GM, Soaje M, Sosa YE, Rodriguez SS, Jahn GA, Goya RG. Estrogen inhibits tuberoinfundibular dopaminergic neurons but does not cause irreversible damage. Brain Res Bull 80: 347-352, 2009.
34. O'Callaghan JP. Quantification of glial fibrillary acidic protein: comparision of slot-immuno-binding assays with a novel sandwich ELISA. Neurotoxicol Teratol 13: 275-281, 1991.
35. Palkovits M, Zaborszky L, Brownstein MJ, Fekete MI, Herman JP, Kanyicska B. Distribution of norepinephrine and dopamine in cerebral cortical areas of the rat. Brain Res Bull 4: 593-601, 1979.
36. Paxinos GW, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1998.
37. Piroli GG, Grillo CA, Ferrini MG, Lux-Lantos V, De Nicola AF. Antagonism by progesterone of diethylstilbestrol-induced pituitary tumorigenesis in Fischer 344 rats: effects on sex steroid receptors and tyrosine hydroxylase mRNA. Neuroendocrinology 63: 530-539, 1996.
38. Reymond MJ, Porter JC. Involvement of hypothalamic dopamine in the regulation of prolactin secretion. Horm Res 22: 142-152, 1985.
39. Saitoh Y, Hikake T, Hayashi S, Iguchi T, Sato T. Involvement of insulin-like growth factor-I for the regulation of prolactin synthesis by estrogen and postnatal proliferation of lactotrophs in the mouse anterior pituitary. Cell Tiss Res 340: 147-158.
40. Schipper H, Brawer JR, Nelson JF, Felicio LS, Finch CE. Role of the gonads in the histologic aging of the hypothalamic arcuate nucleus. Biol Reprod 25: 413-419, 1981.
41. Simpkins JW, Green PS, Gridley KE, Singh M, de Fiebre NC, Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med 103: 19S-25S, 1997.
42. Steyn FJ, Anderson GM, Grattan DR. Expression of ovarian steroid hormone receptors in tuberoinfundibular dopaminergic neurones during pregnancy and lactation. J Neuroendocrinol 19: 788-793, 2007.
43. Wakita T, Shintani F, Yagi G, Asai M, Nozawa S. Combination of inflammatory cytokines increases nitrite and nitrate levels in the paraventricular nucleus of conscious rats. Brain Res 905: 12-20, 2001.
44. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 52: 965-970, 1999.
45. Xing B, Xin T, Hunter RL, Bing G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J Neuroinflammation 5: 4, 2008.
46. Yusuf S, Anand S. Hormone replacement therapy: a time for pause. Can Med Assoc J 167: 357-359, 2002.